Advantame - An overview of the toxicity data

Food and Chemical Toxicology

Volumn 49, Issue SUPPL. 1, 2011, Pages

  Otabe, A ^a   Fujieda, T ^a   Masuyama, T ^a   Ubukata, K ^a   Lee, C ^b  

^a AJINOMOTO CO INC   (Japan)

^b Deva Medical Consulting   (United Kingdom)

Author keywords

Advantame; Carcinogenicity; Human; N N 3 (3 hydroxy 4 methoxyphenyl)propyl aspartyl l phenylalanine 1 methyl ester; Reproductive toxicity; Toxicology

Indexed keywords

ADVANTAME; PLACEBO; SWEETENING AGENT; UNCLASSIFIED DRUG;

ABSORPTION; ARTICLE; CARCINOGENICITY; CHRONIC TOXICITY; DEVELOPMENTAL TOXICITY; DOG; EXCRETION; EXPERIMENTAL MOUSE; EXPERIMENTAL RAT; GENOTOXICITY; HISTOPATHOLOGY; HUMAN; METABOLISM; NONHUMAN; RABBIT; RADIOACTIVITY; REPRODUCTIVE TOXICITY; STRUCTURE ANALYSIS; SUBCHRONIC TOXICITY; TOXICITY; TOXICITY TESTING; TOXICOKINETICS;

ANIMALS; ASPARTAME; DOGS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; MALE; MICE; MOLECULAR STRUCTURE; RATS; SWEETENING AGENTS; TOXICITY TESTS;

ANIMALIA; CANIS FAMILIARIS; RATTUS;

EID: 80755180844     PISSN: 02786915     EISSN: 18736351     Source Type: Journal    
DOI: 10.1016/j.fct.2011.06.046     Document Type: Article

References (20)

1. FDA U.S. Food additives permitted for direct addition to food for human consumption; Neotame. Fed. Regist. (US) 2002, 67:45300-45310.
2. Flamm W.G., Blackburn G.L., Comer C.P., Mayhew D.A., Stargel W.W. Long-term food consumption and body weight changes in neotame safety studies are consistent with the allometric relationship observed for other sweeteners and during dietary restrictions. Regul. Toxicol. Pharmacol. 2003, 38:144-156.
3. HLS, 2002a [unpublished]. Advantame (ANS9801). Tissue distribution in the male rat. Huntingdon Life Sciences Ltd., Huntingdon, Engl. Study sponsored by: Ajinomoto Co. Inc., Tokyo, Japan. AJO 181/013583. Report issued December 17, 2002.
4. HLS, 2002b [unpublished]. Advantame (ANS9801). Tissue distribution in the male dog. Huntingdon Life Sciences Ltd., Huntingdon, Engl. Study sponsored by: Ajinomoto Co. Inc., Tokyo, Japan. AJO 191/022818. Report issued December 13, 2002.
5. HLS, 2004a [unpublished]. Advantame (ANS9801). Determination of the distribution in rats by whole-body autoradiography. Huntingdon Life Sciences Ltd., Huntingdon, Engl. Study sponsored by: Ajinomoto Co. Inc., Tokyo, Japan. AJO 217/042246. Report issued September 28, 2004.
6. HLS, 2004b. Advantame (ANS9801). Toxicity study by dietary administration to Han Wistar rats for 13 Weeks followed by a 4 week recovery period. Huntingdon Life Sciences Ltd., Huntingdon, UK. Study sponsored by: Ajinomoto Co. Inc., Tokyo, Japan. Report AJO 176/014075, issued October 29, 2004.
7. HLS, 2005 [unpublished]. Advantame (ANS9801). Toxicity study by dietary administration to beagle dogs for 13 weeks followed by a 4 week recovery period. Huntingdon Life Sciences Ltd., Huntingdon, Engl. Study sponsored by: Ajinomoto Co. Inc., Tokyo, Japan. AJO 179/014664. Report issued March 24, 2005.
8. ICH, 1993. Detection of toxicity to reproduction for medicinal products: S5A. International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH Harmonised Tripartite Guideline).
9. JECFA, 2004. Safety Evaluation of Certain Food Additives and Contaminants. 61st Meeting of the Joint FAO/WHO Expert Committee on Food Additives (JECFA), June 10-19, 2003. World Health Organization (WHO), Geneva, Switz. WHO Food Additives Series, No. 52, pp. 85-135.
10. Kirkland D., Aardema M., Henderson L., Müller L. Evaluation of the ability of a battery of three in vitro genotoxicity tests to discriminate rodent carcinogens and non-carcinogens. I. sensitivity, specificity and relative predictivity [published correction appears in Mutat. Res. 588, 70]. Mutat. Res. 2005, 584:1-256.
11. Kirkland D., Aardema M., Müller L., Hayashi M. Evaluation of the ability of a battery of three in vitro genotoxicity tests to discriminate rodent carcinogens and non-carcinogens. II. Further analysis of mammalian cell results, relative predictivity and tumour profiles. Mutat. Res. 2006, 608:29-42.
12. Magnuson B.A., Burdock G.A., Doull J., Kroes R.M., Marsh G.M., Pariza M.W., Spencer P.S., Waddell W.J., Walker R., Williams G.M. Aspartame: a safety evaluation based on current use levels, regulations, and toxicological and epidemiological studies. Crit. Rev. Toxicol. 2007, 37:629-727.
13. Mann S.W., Yuschak M.M., Amyes S.J., Aughton P., Finn J.P. A combined chronic toxicity/carcinogenicity study of sucralose in sprague-dawley rats. Food Chem. Toxicol. 2000, 38:S71-S89.
14. Matsuzawa T., Nakata M., Goto I., Tsushima M. Dietary deprivation induces fetal loss and abortion in rabbits. Toxicology 1981, 22:255-259.
15. Müller L., Kasper P. Human biological relevance and the use of threshold-arguments in regulatory genotoxicity assessment: experience with pharmaceuticals. Mutat. Res. 2000, 464:19-34.
16. Petrere J.A., Rohn W.R., Grantham L.E., Andersen J.A. Food restriction during organogenesis in rabbits: effects on reproduction and the offspring. Fundam. Appl. Toxicol. 1993, 21:517-522.
17. Tennant R.W., Margolin B.H., Shelby M.D., Zeiger E., Haseman J.K., Spalding J., Caspary W., Resnick M., Stasiewicz S., Anderson B., Minor R. Prediction of chemical carcinogenicity in rodents from in Vitro genetic toxicity assays. Science 1987, 236:933-941.
18. WHO, 1987. Principles for the Safety Assessment of food additives and contaminants in food. World Health Organization (WHO), International Programme on Chemical Safety (IPCS); Geneva, Switz., Environmental Health Criteria, No. 70. Available from:. http://www.inchem.org/documents/ehc/ehc/ehc70.htm.
19. WHO, 2007. GEMS/Food consumption cluster diets: regional per capita consumption of raw and semi-processed agricultural commodities. World Health Organization (WHO), Global Environment Monitoring System Food Contamination Monitoring and Assessment Programme and Food Safety Department, Geneva, Switz.
20. Zeiger E. Identification of rodent carcinogens and noncarcinogens using genetic toxicity tests: premises, promises, and performance. Regul. Toxicol. Pharmacol. 1998, 28:85-95.